2021
DOI: 10.1016/j.ebiom.2021.103514
|View full text |Cite
|
Sign up to set email alerts
|

Personalised, image-guided, noninvasive brain stimulation in gliomas: Rationale, challenges and opportunities

Abstract: Malignant brain tumours are among the most aggressive human cancers, and despite intensive effort s made over the last decades, patients' survival has scarcely improved. Recently, high-grade gliomas (HGG) have been found to be electrically integrated with healthy brain tissue, a communication that facilitates tumour mitosis and invasion. This link to neuronal activity has provided new insights into HGG pathophysiology and opened prospects for therapeutic interventions based on electrical modulation of neural a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 100 publications
(180 reference statements)
0
8
0
Order By: Relevance
“…27,28 All previous structural and functional connectome analyses have pointed out that network features in brain tumors would provide more useful information for detecting the accumulation of glioma cells and deciding the treatment therapy. 29 Therefore, more studies on the brain network of gliomas should be conducted to broaden and deepen the understanding of brain tumors.…”
Section: Discussionmentioning
confidence: 99%
“…27,28 All previous structural and functional connectome analyses have pointed out that network features in brain tumors would provide more useful information for detecting the accumulation of glioma cells and deciding the treatment therapy. 29 Therefore, more studies on the brain network of gliomas should be conducted to broaden and deepen the understanding of brain tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Glioma is the most common malignant primary brain tumor, accounting for 15% of all brain tumors (Ostrom et al, 2021;Siegel et al, 2022). However, despite decades of intensive efforts, glioma remains one of the most challenging cancers to treat, with limited improvement in patient survival (Sprugnoli et al, 2021). Glioblastoma (GBM), the most frequent and aggressive high-grade glioma (HGG, WHO IV), is associated with a mean survival of approximately 16 to 18 months from diagnosis(Lara-Velazquez et al, 2017; Nayak and Reardon, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the basis of GBM treatment is still surgical removal of the tumor followed by adjuvant chemotherapy and radiation therapy (the STUPP protocol) [ 60 ]. While several personalized molecular and immune treatment strategies have been tried in high-grade gliomas, their benefit thus far appears limited [ 61 , 62 , 63 , 64 ].…”
Section: Review Of the Literaturementioning
confidence: 99%